Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540761 · ClinicalTrials.gov registry record · NA
Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
A NA study of Coronary Arteriosclerosis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 3
- Study locations
NCT00540761 is a NA study of Coronary Arteriosclerosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 320 participants, below the 689-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT00540761, a NA study of Coronary Arteriosclerosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 3
- Study locations
Study Summary
Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in people who have had a heart attack. This study will use a new imaging technique called optical frequency domain imaging (OFDI) to examine the presence of vulnerable plaques in people with coronary artery disease.
Conditions Studied
Interventions
- DEVICE OFDI imaging
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
- Lahey Clinic - Burlington
New York
- Columbia Presbyterian Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2007-07-25 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00540761
The ClinicalTrials.gov registry entry for NCT00540761 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 689-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (54% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Arteriosclerosis appearing as the primary indexed condition, and to 1 intervention - of which OFDI imaging is the first listed.
NCT00540761 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT00540761 about?
NCT00540761 is a clinical study titled "Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique". Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in peo...
What is the current status of trial NCT00540761?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2007-07-25. Estimated completion is 2028-12.
What conditions does trial NCT00540761 study?
This clinical trial studies the following conditions: Coronary Arteriosclerosis.
What interventions are being tested in trial NCT00540761?
The interventions under investigation include: OFDI imaging (DEVICE).
Who is sponsoring clinical trial NCT00540761?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540761 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Arteriosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
COMPLETED · NA
-
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
COMPLETED · NA
-
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
COMPLETED · NA
-
Multidisciplinary Inpatient Palliative Care Intervention
COMPLETED · NA
-
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.